نتایج جستجو برای: people who inject drugs pwid

تعداد نتایج: 1254320  

2016
Debra L. Karch Kristen Mahle Gray Jing Shi H. Irene Hall

OBJECTIVES Assess outcomes along the care continuum for HIV-infected people who inject drugs (PWID), by type of facility and stage of infection at diagnosis. METHODS Data reported by 28 jurisdictions to the National HIV Surveillance System by December 2014 were used to identify PWID aged ≥13 years, diagnosed with HIV infection before December 31, 2013. Analyses used the CDC definition of link...

Journal: :Journal of viral hepatitis 2015
A Cousien V C Tran S Deuffic-Burban M Jauffret-Roustide J-S Dhersin Y Yazdanpanah

Equipment sharing among people who inject drugs (PWID) is a key risk factor in infection by hepatitis C virus (HCV). Both the effectiveness and cost-effectiveness of interventions aimed at reducing HCV transmission in this population (such as opioid substitution therapy, needle exchange programmes or improved treatment) are difficult to evaluate using field surveys. Ethical issues and complicat...

Journal: :The Journal of the Association of Nurses in AIDS Care : JANAC 2013
Alice K Asher Judith A Hahn Marie-Claude Couture Kelsey Maher Kimberly Page

Dramatic rises in injection drug use (IDU) in sub-Saharan Africa account for increasingly more infections in a region already overwhelmed by the HIV epidemic. There is no known estimate of the number of people who inject drugs (PWID) in the region, or the associated HIV prevalence in PWID. We reviewed literature with the goal of describing high-risk practices and exposures in PWID in sub-Sahara...

Journal: :Drug and alcohol dependence 2017
Rob Bielen Christophe Moreno Hans Van Vlierberghe Stefan Bourgeois Jean-Pierre Mulkay Thomas Vanwolleghem Wim Verlinden Christian Brixko Jochen Decaestecker Chantal De Galocsy Filip Janssens Mike Cool Lode Van Overbeke Christophe Van Steenkiste François D'heygere Wilfried Cools Frederik Nevens Geert Robaeys

BACKGROUND AND AIM Hepatitis C viral infection (HCV) has become a curable disease due to the development of direct acting antivirals (DAA). The WHO has set a target to eliminate HCV completely. Therefore, people who inject drugs (PWID) also need to be treated. In this study, we compared the real-life uptake and outcome of DAA treatment for HCV in PWID and non-PWID. METHODS We performed a nati...

2017
Ian Duncan Patrick Habecker Roberto Abadie Ric Curtis Bilal Khan Kirk Dombrowski

BACKGROUND People who inject drugs (PWID) take on significant risks of contracting blood-borne infection, including injecting with a large number of partners and acquiring needles from unsafe sources. When combined, risk of infection can be magnified. METHODS Using a sample of PWID in rural Puerto Rico, we model the relationship between a subject's number of injection partners and the likelih...

Journal: Addiction and Health 2015

Background: Needle-syringe programs (NSP) have been running in Iran since 2002. However, the coverage of such program among the NSP clients at the individual level was not studies yet. This study aimed to determine the client coverage of NSP and its correlation with high injection-related risk behaviors. Methods: A cross-sectional survey was conducted in Kermanshah province, Iran, in 2014. 230 ...

Journal: :The Lancet Infectious Diseases 2016

2016
Daniel J. Smith Ashly E. Jordan Mayu Frank Holly Hagan

BACKGROUND Hepatitis C virus (HCV) infection causes significant morbidity and mortality among people who inject drugs (PWID) and HIV+ men who have sex with men (MSM). Characterizing spontaneous viral clearance of HCV infection among PWID and HIV+ MSM is important for assessing the burden of disease and treatment strategies in these populations. METHODS Electronic and other searches of medical...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید